 NASHVILLE, Tenn., April 14, 2021 GLOBE NEWSWIRE -- Harrow Health, Inc. NASDAQ: HROW, an ophthalmic-focused healthcare company, today announced it has commenced an underwritten registered public offering of 25 million aggregate principal amount of senior notes due 2026 the Notes, subject to market and certain other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional senior notes in connection with the offering. 